Bruce Maryanoff

Dr. Bruce E. Maryanoff retired from Johnson & Johnson company in 2010. While at J&J he rose to the highest scientific position, Distinguished Research Fellow. He retired in 2010, after 36 years of service, and is now affiliated with The Scripps Research Institute (La Jolla, CA), the Baruch S. Blumberg Institute (Doylestown, PA), and the Pennsylvania Drug Discovery Institute (Doylestown). Dr. Maryanoff has made numerous contributions to medicinal and organic chemistry. He is an internationally renowned expert in drug design and drug discovery. From 1976−1992, he worked on central nervous system therapeutics, with a focus on anticonvulsants and antidepressants. Dr. Maryanoff discovered and championed TOPAMAX® topiramate, a unique sugar sulfamate compound, which was marketed for treating epilepsy and migraine headaches, and achieved peak sales of nearly $3 billion/year.